Liangxing Wang

机构：Wenzhou Medical University, First Affiliated Hospital of Wenzhou Medical University · ORCID：0000-0002-7173-3581

发表论文 213 篇 · 总被引 4372 次 · h-index 37

代表论文

Analyzing the molecular mechanism of xuefuzhuyu decoction in the treatment of pulmonary hypertension with network pharmacology and bioinformatics and verifying molecular docking (2023 · Computers in Biology and Medicine · 被引 60)
Synergizing the enhanced RIME with fuzzy K-nearest neighbor for diagnose of pulmonary hypertension (2023 · Computers in Biology and Medicine · 被引 60)
Emergence of hypervirulent and carbapenem-resistant Klebsiella pneumoniae from 2014 - 2021 in Central and Eastern China: a molecular, biological, and epidemiological study (2024 · BMC Microbiology · 被引 36)
Circ-Ntrk2 acts as a miR-296-5p sponge to activate the TGF-β1/p38 MAPK pathway and promote pulmonary hypertension and vascular remodelling (2023 · Respiratory Research · 被引 28)
Parthenolide attenuates hypoxia-induced pulmonary hypertension through inhibiting STAT3 signaling (2024 · Phytomedicine · 被引 22)
Gracillin relieves pulmonary fibrosis by suppressing the STAT3 axis (2023 · Journal of Ethnopharmacology · 被引 17)